Skip to Main Content (Press Enter)
×
Home
Corsi
Insegnamenti
Professioni
Persone
Pubblicazioni
Strutture
Terza Missione
Competenze
IT
EN
☰
Competenze e Professionalità
|
UNIFIND
-
Competenze e Professionalità
unime.it
IT
EN
×
Home
Corsi
Insegnamenti
Professioni
Persone
Pubblicazioni
Strutture
Terza Missione
Competenze
☰
Pubblicazioni
JOURNAL OF CLINICAL ONCOLOGY
Rivista
Codice:
E091050
ISSN:
0732-183X
Dati Generali
Dati Generali
Pubblicazioni (82)
Pulisci
Ordina Pubblicazioni:
ascendente
decrescente
ARTO trial-(NCT03449719): Early results from a phase II randomized trial testing stereotactic body radiation therapy in patients with oligometastatic castration-resistant prostate cancer undergoing I line treatment with abiraterone acetate
Abstract
Activity and safety of gefitinib and erlotinib in metastatic non-small cell lung cancer (NSCLC): A comparative analysis.
Abstract
Activity and tolerability of cisplatin (CDDP) and fotemustine (FTM) in non-small cell lung cancer (NSCLC) patients (PTS) with brain metastases (BM): A multicentric phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM).
Abstract
AlphaB-crystallin (aBC) expression in breast cancer brain metastases (BM) and primary breast cancer (pBC) with eventual BM and association with outcome
Abstract
Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis
Articolo
Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: A phase II study
Articolo
Clinical management of long-term cancer survivors [3]
Articolo
EGFR compound mutants and survival on erlotinib in non-small cell lung cancer (NSCLC) patients (p) in the EURTAC study.
Abstract
EML4-ALK fusion gene in lung adenocarcinoma: A retrospective analysis of the outcome of cisplatin plus pemetrexed treated patients.
Abstract
ERLOTINIB IN A PATIENT WITH ACUTE MYELOGENOUS LEUKEMIA AND CONCOMITANT NON-SMALL-CELL LUNG CANCER
Articolo
Effect of treatment with amifostine in patients with myelodisplastic syndromes on clinical outcome and apoptosis in bone marrow
Articolo
Epstein-Barr virus infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin's lymphomas
Articolo
GENE EXPRESSION PROFILING DOES NOT IDENTIFY MOLECULAR SUBGROUP AMONG NODAL PERIPHERAL T-CELL LYMPHOMAS
Articolo
Gemcitabine (GEM) and liposomal doxorubicin (PLD) in recurrent/metastatic breast carcinoma: A phase II study
Abstract
Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian lung cancer project
Articolo
Hereditary breast/ovarian cancer families: The impact of mutation prediction models on BRCA1/2 mutation screening costs.
Abstract
How cells respond to interferons.
Articolo
Immunochemotherapy with temozolomide and rituximab for central nervous system lymphomas in an elderly population.
Articolo
Inactivation of E-cadherin byTrop-2 drives colon cancer metastasis
Abstract
Initial Panitumumab Plus Fluorouracil, Leucovorin, and Oxaliplatin or Plus Fluorouracil and Leucovorin in Elderly Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The PANDA Trial by the GONO Foundation
Articolo
Integrating psychosocial care into routine cancer care: A stepped-wedge design cluster randomized controlled trial (SWD-RCT) to evaluate effectiveness of the HuCare Quality Improvement Strategy (HQIS) on health-related quality of life (HRQoL)
Abstract
Is it better to transfer long-term cancer survivors to general practitioners or develop clinics for long-term survivors within the cancer centers?
Articolo
Is long-term fatigue in patients with cancer an infrequent symptom?
Articolo
Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS).
Articolo
Lymph Node Micrometastases Do Influence Breast Cancer Outcome
Articolo
MONITORING TREATMENT AND SURVIVAL IN CHRONIC MYELOID LEUKAEMIA
Articolo
MOPP EBV CAD HYBRID CHEMOTHERAPY WITH OR WITHOUT LIMITED RADIOTHERAPY IN ADVANCED OR UNFAVORABLY PRESENTING HODGKINS- DISEASE - A REPORT FROM THE ITALIAN-LYMPHOMA-STUDY-GROUP
Articolo
Management of skin toxicity and cetuximab-based regimen compliance in first-line chemotherapy of metastatic colorectal cancer (mCRC) patients (pts): Results of observer study.
Abstract
Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia
Articolo
May the istotype influence the response to pemetrexed in patients with non small cell lung cancer? Preliminary data of our clinical experience.
Abstract
Microsatellite instability is an independent indicator of recurrence in sporadic stage I-II endometrial adenocarcinoma
Articolo
Molecular and clinical analysis of predictive biomarkers to anti-EGFR inhibitors in metastatic colorectal cancer (mCRC): Interaction among early tumor shrinkage, skin toxicities, and RAS status.
Abstract
Multicentric Castleman disease: an unusual breast lump.
Articolo
Myeloid-derived suppressor cells absolute counts in predicting durable response to R-CHOP in patients with follicular lymphoma.
Abstract
NEMESI: A retrospective observational longitudinal study to investigate italian early breast cancer (EBC)patient characteristics and treatment.
Abstract
Natural history of malignant bone disease in non-small cell lung cancer: Preliminary results of a multicenter bone metastasis survey.
Abstract
Negative hyperselection of patients with RAS and BRAF wild-type metastatic colorectal cancer who received panitumumab-based maintenance therapy
Articolo
Novel domain-targeted anti-Trop-2 monoclonal antibodies to elicit therapeutic synergy against multiple human cancers
Abstract
Observational study to evaluate the pattern of trastuzumab (T) use and survival outcomes in HER2-positive (HER2+) early breast cancer (EBC): Regional Southern Italy experience.
Abstract
Osimertinib and dihydroartemisinin: A novel drug combination targeting head and neck squamous cell carcinoma.
Abstract
Overexpression of the polycythemia rubra vera-1 gene in essential thrombocythemia
Articolo
PIK3CA mutations in breast cancer: a potential marker
Abstract
PRELIMINARY REPORT OF RITUXIMAB AND INTERLEUKIN-2(IL-2)IN PATIENTS WITH RELAPSED HODGKIN DISEASE OF CLASSICAL TYPE
Articolo
Palliative radiotherapy: Run with the hare and hunt with the hounds
Articolo
Patient (pt) characteristics and treatment patterns in the radium (Ra)-223 REASSURE observational study
Abstract
Pegylated liposomal doxorubicin in combination with gemcitabine in elderly women with locally advanced or metastatic breast cancer: safety and activity results of our clinical experience.
Abstract
Phase III Randomized Trial Comparing Three Platinum-Based Doublets in Advanced Non-Small Cell Lung Cancer.
Abstract
Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer
Articolo
Polycythemia vera and essential thrombocytemia treated with IFN-ALPHA2a: Evidence of a significant clinical activity and molecular response.
Abstract
Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancerreceiving chemotherapy: a prognostic analysis of the multicenter Italian lungcancer in the elderly study.
Articolo
Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy
Articolo
Prognostic significance of elevated pretreatment serum CA-125 in patients (pts) with epithelial ovarian cancer (CEO) treated with surgery and platinum/taxane-based chemotherapy.
Abstract
Prognostic value of methlylenetetrahydrofolate reductase (MTHFR), thymidylate synthase (TS) promoter, and p53 codon 72 variants and survival in advanced non-small cell lung cancer (NSCLC).
Abstract
Prospective, multicenter, randomized trial of a new organizational modality for providing information and support to cancer patients.
Articolo
Quality of life (QOL) analysis of an ILCP trial comparing three platinum-based doublets for advanced non-small cell lung cancer (NSCLC)
Abstract
Questionable Validity of Cardiac Risk Score on the Basis of the NSABP B-31 Model
Articolo
Recurrence of breast cancer in elderly women
Articolo
Retrast: Retreatment after adjuvant trastuzumab—Our regional southern Italy experience.
Abstract
Risk of second malignant neoplasm among patients with lymphoma
Articolo
Role of MTHFR polymorphisms as predictive markers of acute toxicity during 5-fluorouracil based chemotherapy for colorectal cancer: Preliminary data.
Abstract
Safety and clinical activity of trastuzumab (TSM) containing therapies in heavily pretreated patients with metastatic breast cancer (MBC): A five-year experience
Abstract
Safety of trastuzumab, alone or in combination, in elderly patients with HER2-positive breast cancer: A 5-year case series.
Abstract
Second-line therapy in advanced non-small cell lung cancer: Cytotoxic agents or tyrosine kinase inhibitors? Our experience.
Abstract
Selective killing of human cancer cells by targeting a fusion mRNA between CYCLIN D1 and TROP2
Abstract
Sequencing radium 223 (RA223) for metastatic castration-resistant prostate cancer (mCRPC) patients (pts) in the daily practice: Preliminary results from a retrospective study in Italian centers
Articolo
Sequential tamoxifen and aminoglutethimide versus tamoxifen alone in the adjuvant treatment of postmenopausal breast cancer patients: results of an Italian cooperative study
Articolo
Should the Use of Surveillance Imaging in Diffuse Large B-Cell Lymphoma Be Discontinued?
Articolo
Simplified risk stratification model for patients with Waldenström macroglobulinemia
Articolo
Skin toxicity associated with outcome to erlotinib in non-small cell lung cancer (NSCLC) patients (p) with EGFR mutations in the EURTAC study.
Abstract
Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO)
Articolo
TP53 Gene Indels Impact on Cancer Outcomes
Articolo
TROP2 is a major determinant of growth and metastatic spreading of human cancer
Articolo
Takotsubo syndrome in a patient treated with sunitinib for renal cancer
Articolo
Targeting Trop-2 as a Cancer Driver
Articolo
The Hu2G10 mAb targets the cleaved-activated form of Trop-2 and exploits vulnerability of multiple human cancers
Abstract
The Mam-1 GOCSI Trial: a Randomised Trial with Factorial Design of Chemo-Endocrine Adjuvant Treatment in Node-Positive (N+) Early Breast Cancer (EBC).
Abstract
The nuclear factor kB (NFkB) and Notch signaling pathways and BRCA1 mRNA expression in stage IV non-small cell lung cancer (NSCLC) patients (p).
Abstract
Torch study: How much longer should we continue to use erlotinib in unselected patients with non-small-cell lung cancer?
Articolo
Trials on preoperative chemotherapy in resectable colorectal liver metastases need prospective evaluation of predictive factors of response
Articolo
Trop-2 inactivates E-cadherin and drives colon cancer metastasis
Abstract
Ultra-hypofractionated radiotherapy and concomitant oral relugolix for treatment of intermediate risk prostate cancer (ULTRA-HERO)
Articolo
Ultrasound Molecular Imaging With BR55 in Patients With Breast and Ovarian Lesions: First-in-Human Results
Articolo
No Results Found
«
‹
{pageNumber}
›
»
{startItem} - {endItem} di {itemsNumber}
5 per pagina
10 per pagina
30 per pagina
vedi tutti